New PhRMA report: More than 170 medicines in development for diabetes

Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the complexity of the disease. Because diabetes is the seventh leading cause of death in the United States, the need for innovative treatments and therapies is greater than it ever has been. America’s biopharmaceutical companies are committed to developing new and innovative medicines for patients in need. And today, patients with diabetes can have more hope than ever before with the significant progress offered by rapid advances in science.